Ischemia times and donor serum creatinine in relation to renal graft failure

Background. The results of renal transplantation are dependent on many variables. To simplify the decision process related to a kidney offer, the authors wondered which variables had the most important influence on the graft failure risk. Methods. All transplant patients (n=1,124) between January 1981 and July 2000 were included in the analysis (2.6% had missing values). The variables included were donor and recipient age and gender, recipient original disease, race, donor origin, current smoking, cardiovascular disease, body weight, peak and current panel reactive antibody (PRA), number of preceding transplants, type and duration of renal replacement therapy, and time since failure of native kidneys. Also, human leukocyte antigen (HLA) identity or not, first and second warm and cold ischemia times, left or right kidney and fossa, donor kidney anatomy, donor serum creatinine and proteinuria, and transplantation year were included. Results. In a multivariate model, cold ischemia time and its time-dependent variable significantly influenced the graft failure risk censored for death (P <0.0001) independent of any of the other risk factors. The influence primarily affected the risk in the first week after transplantation; thereafter, it gradually disappeared during the first year after transplantation. Donor serum creatinine also significantly influenced the graft failure risk in a time-dependent manner (P <0.0001). The risk of a high donor serum creatinine is already enlarged in the immediate postoperative phase and increases thereafter; the curve is closely related to the degree of the elevation. The other variables with a significant influence on the graft failure rate were, in order of decreasing significance, recipient age, donor gender, donor age, HLA identity, transplantation year, preceding transplantations, donor origin, and peak PRA. Conclusions. Donor serum creatinine and cold ischemia time are important time-dependent variables independently influencing the risk of graft failure censored for death. The best strategy for improving the results of cadaveric transplantations is to decrease the cold ischemia time and to allocate kidneys from donors with an elevated serum creatinine to low-risk recipients.

[1]  A. Matas,et al.  Living donors >55 years: to use or not to use? , 1999, Transplantation.

[2]  L. Ratner,et al.  Impact of donor/recipient traits independent of rejection on long-term renal function. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  D. Slakey,et al.  Baseline glomerular size as a predictor of function in human renal transplantation. , 1998, Transplantation.

[4]  M. Joffe,et al.  Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. , 2001, The New England journal of medicine.

[5]  J. Chapman,et al.  EFFECT OF HISTOLOGICAL DAMAGE ON LONG-TERM KIDNEY TRANSPLANT OUTCOME , 2001, Transplantation.

[6]  J. Cecka The UNOS Scientific Renal Transplant Registry. , 1999, Clinical transplants.

[7]  P. Fauchald,et al.  Unrelated living donors in 141 kidney transplantations: a one-center study. , 1998, Transplantation.

[8]  D. Gjertson A multi-factor analysis of kidney graft outcomes at one and five years posttransplantation: 1996 UNOS Update. , 1996, Clinical transplants.

[9]  F. Port,et al.  Relationship of recipient age and development of chronic allograft failure. , 2000, Transplantation.

[10]  A. Matas,et al.  Living unrelated donors in kidney transplants: better long-term results than with non-HLA-identical living related donors? , 1999, Transplantation.

[11]  W. Lye,et al.  Biopsy-proven resolution of steroid-resistant acute rejection with basiliximab therapy in a renal allograft recipient. , 2001, Transplantation proceedings.

[12]  J Karpinski,et al.  Outcome of kidney transplantation from high-risk donors is determined by both structure and function. , 1999, Transplantation.

[13]  S. Hariharan,et al.  Improved graft survival after renal transplantation in the United States, 1988 to 1996. , 2000, The New England journal of medicine.

[14]  J. Carter,et al.  Prolonged cold ischemia time obviates the benefits of 0 HLA mismatches in renal transplantation. , 2000, Archives of surgery.

[15]  H. Wolters,et al.  Basiliximab in the therapy of acute rejection after organ transplantation. , 2001, Transplantation proceedings.

[16]  R. Zietse,et al.  The vanishing importance of age in renal transplantation. , 1999, Transplantation.

[17]  S Takemoto,et al.  High survival rates of kidney transplants from spousal and living unrelated donors. , 1995, The New England journal of medicine.

[18]  J. Heaf,et al.  Hyperfiltration, creatinine clearance and chronic graft loss. , 1998, Clinical transplantation.

[19]  R. Zietse,et al.  The impact of donor age on renal graft survival. , 2000, Transplantation proceedings.

[20]  B D Kahan,et al.  The impact of HLA mismatches on the survival of first cadaveric kidney transplants. , 1994, The New England journal of medicine.

[21]  B. Brenner,et al.  Antigen-independent determinants of cadaveric kidney transplant failure. , 1996, JAMA.

[22]  M. Burdelski,et al.  First experience with basiliximab in pediatric liver graft recipients , 2001, Pediatric transplantation.

[23]  O. Schück,et al.  Adverse effect of donor arteriolosclerosis on graft outcome after renal transplantation. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  J. Mcgregor,et al.  An alternative approach for statistical analysis of kidney transplant data: multivariate analysis of single-center experience. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  B. Brenner,et al.  Antigen-independent determinants of graft survival in living-related kidney transplantation. , 1997, Kidney international. Supplement.

[26]  E. Messing,et al.  Living Related and Unrelated Donors for Kidney Transplantation A 28‐Year Experience , 1995, Annals of surgery.

[27]  H. Isoniemi,et al.  Histopathological findings in renal allografts at time of transplantation and correlation with onset of graft function* , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[28]  J. Carter,et al.  EVALUATION OF THE OLDER CADAVERIC KIDNEY DONOR: THE IMPACT OF DONOR HYPERTENSION AND CREATININE CLEARANCE ON GRAFT PERFORMANCE AND SURVIVAL12 , 2000, Transplantation.

[29]  T. Peters,et al.  Cold Ischemia And Outcome In 17,937 Cadaveric Kidney Transplants , 1995, Transplantation.

[30]  J. C. Houwelingen,et al.  PROGNOSTIC INDICES TO PREDICT SURVIVAL OF FIRST AND SECOND RENAL ALLOGRAFTS , 1991, Transplantation.

[31]  H. V. van Houwelingen,et al.  Permanent detrimental effect of nonimmunological factors on long-term renal graft survival: a parsimonious model of time-dependency. , 1999, Transplantation.

[32]  K. Uchida,et al.  Histological factors of 1-h biopsy influencing the delayed renal function and outcome in cadaveric renal allografts. , 1999, Clinical transplantation.

[33]  U. Neumann,et al.  A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantation. , 1998, Clinical transplantation.

[34]  P. Dyer,et al.  Importance of minimizing HLA-DR mismatch and cold preservation time in cadaveric renal transplantation. , 1996, Transplantation.

[35]  A. Lu,et al.  Severe glomerular sclerosis is not associated with poor outcome after kidney transplantation. , 2000, American journal of surgery.

[36]  N Bilgin,et al.  Living unrelated donor kidney transplantation. , 1992, Transplantation Proceedings.

[37]  W. Weimar,et al.  Anti-CD25 therapy reveals the redundancy of the intragraft cytokine network after clinical heart transplantation. , 1999, Transplantation.

[38]  S. Greenstein,et al.  Reassessment of the value of post-vascularization biopsy performed at renal transplantation: the effects of arteriosclerosis. , 1994, The Journal of urology.